Showing results (4471-4480 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|October 12, 2019
Nanoparticles from Actinobacteria: A Potential Target to Antimicrobial TherapyPalaniappan Sivasankar, Subramaniam Poongodi, Palaniappan Seedevi, et al.Current Pharmaceutical Design|October 13, 2019
NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's TherapyMd Tanvir Kabir, Mohammad A Sufian, Md Sahab Uddin, et al.Current Pharmaceutical Design|October 16, 2019
Nanoparticle-Mediated Drug Delivery: Blood-Brain Barrier as the Main Obstacle to Treating Infectious Diseases in CNSBrenna Louise Cavalcanti Gondim, Jonatas da Silva Catarino, Marlos Aureliano Dias de Sousa, et al.Current Pharmaceutical Design|October 16, 2019
Silica Nanoparticles for Insect Pest ControlMariano Cáceres, Claudia V Vassena, M Dolores Garcerá, et al.Current Pharmaceutical Design|September 25, 2018
Pilot Study of Eyesight Characteristics and Thickness of the Retinal Nerve Fiber and Ganglion Cell-inner Plexiform Layers in Adolescent Patients with Type one Diabetes Mellitus on an Insulin PumpDorota Raczyńska, Beata Bzoma, Katarzyna Sielachowicz, et al.Current Pharmaceutical Design|September 25, 2018
The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion InjuryYoshimasa Oyama, Colleen Marie Bartman, Jennifer Gile, et al.Current Pharmaceutical Design|July 4, 2019
Ozonated Oils and Cutaneous Wound HealingYunsook Lim, Heaji Lee, Brittany Woodby, et al.Current Pharmaceutical Design|July 12, 2019
The Protective Mechanism of Cannabidiol in Cardiac Injury: A Systematic Review of Non-Clinical StudiesMohammad R H Shayesteh, Hamed Haghi-Aminjan, Mohammad J Mousavi, et al.Current Pharmaceutical Design|March 4, 2010
High-density lipoprotein at the interface of type 2 diabetes mellitus and cardiovascular disordersSophie Van Linthout, Frank Spillmann, Heinz-Peter Schultheiss, et al.Current Pharmaceutical Design|March 4, 2010
High-density lipoprotein quantity or quality for cardiovascular prevention?Laura Calabresi, Monica Gomaraschi, Guido FranceschiniPageof 1,008